Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL

被引:87
作者
Hattori, Y
Suzuki, M
Tsushima, M
Yoshida, M
Tokunaga, Y
Wang, Y
Zhao, D
Takeuchi, M
Hara, Y
Ryomoto, KI
Ikebuchi, M
Kishioka, H
Mannami, T
Baba, S
Harano, Y
机构
[1] Natl Cardiovasc Ctr, Div Atherosclerosis Metab & Clin Nutr, Suita, Osaka 565, Japan
[2] Natl Cardiovasc Ctr, Div Prevent Med, Suita, Osaka 565, Japan
[3] Konan Univ, Kobe, Hyogo 658, Japan
[4] Kobe City Coll Technol, Kobe, Hyogo 65121, Japan
[5] Kyoto Medix KK, Tokyo, Japan
关键词
hyperapobetalipoproteinemia; LDL apo B; LDL-chol; small dense LDL;
D O I
10.1016/S0021-9150(98)00034-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estimation of LDL-chol and LDL-apo B is useful for the diagnosis of hyperapobetalipoproteinemia (normal LDL-chol with increased LDL-apo B), which is one of the most commonly occurring lipoprotein disorders associated with atherosclerotic cardiovascular diseases. The LDL-chol/LDL-apo B ratio reflects the level of small dense LDL, which is an important risk factor for IHD, CVD and ASO. In order to estimate LDL-apo B and LDL-chol/LDL-apo B ratio from blood chol, TG, HDL-chol and apo B values, we developed a formula for LDL-chol {0.94Chol-0.94HDL-chol-0.19TG}, LDL-apo B {apo B-0.09Chol+0.09HDL-chol-0.08TG}, and LDL-chol/LDL-apo B [{0.94Chol-0.94HDL-chol-0.19TG}/{apo B-0.09Chol + 0.09HDL-chol-0.08TG}], using ultracentrifugal data from 2179 subjects. These were calculated by the least squares method on the assumption that a certain compositional relationship exists between Chol, TG and apo B in VLDL, IDL and LDL. Friedewald's formula for LDL-chol (Chol-HDL-chol-0.2TG) includes IDL-chol, but the present new formula theoretically excludes IDL-chol. It suggests a better estimation for the correct LDL-chol. Estimated LDL-apo B is useful for the diagnosis of hyperapobetalipoproteinemia and detection of small dense LDL. Without performing ultracentrifuge, additional information is obtained for the quantitative and qualitative alteration of LDL, such as small dense LDL. The above formulae and a new classification of lipoproteinemia including apo B were applied to the analyses of lipoprotein profiles of subjects with cardiovascular diseases, which were compared with those in the general population. Hyperapobetalipoproteinemia with high TG was observed 2-3 times more frequently in subjects with CAD, MI and ASO than in the Suita population. Lower ratios of LDL-chol/LDL-apo B, reflecting preponderance of small dense LDL, were observed in the above three groups. Type IIb and combined low HDL-chol were also frequent phenotypes in CAD, A-Th and ASO. The present formulae are useful for the detailed analyses of lipoprotein disorders in both qualitative as well as quantitative aspects. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:289 / 299
页数:11
相关论文
共 19 条
[1]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[2]  
FREUND J, 1992, SAS SYSTEM REGRESSIO
[3]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[4]   Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects [J].
Harano, Y ;
Kageyama, A ;
Nakao, Y ;
Hara, Y ;
Suzuki, M ;
Sato, A ;
Ikebuchi, M ;
Shinozaki, K ;
Tsushima, M .
DIABETES, 1996, 45 :S31-S34
[5]   HOMOZYGOUS HYPOBETALIPOPROTEINEMIA WITH SPARED CHYLOMICRON FORMATION [J].
HARANO, Y ;
KOJIMA, H ;
NAKANO, T ;
HARADA, M ;
KASHIWAGI, A ;
NAKAJIMA, Y ;
HIDAKA, TH ;
OHTSUKI, T ;
SUZUKI, T ;
TAMURA, A ;
FUJII, T ;
NISHIMURA, T ;
OHTAKA, T ;
SHIGETA, Y .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (01) :1-7
[6]  
HARANO Y, 1990, PROGR OBESITY RES, P299
[7]  
HARANO Y, 1990, JPN J CLIN PATHOL, V38, P861
[8]  
Hatch F T, 1968, Adv Lipid Res, V6, P1
[9]   Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension [J].
Ikeda, K ;
Suzuki, M ;
Ikebuchi, M ;
Hara, Y ;
Tsushima, M ;
Yamamoto, A ;
Harano, Y .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1995, 9 (04) :227-229
[10]   PREVALENCE OF HYPERAPOBETALIPOPROTEINEMIA AND OTHER LIPOPROTEIN PHENOTYPES IN MEN (AGED LESS-THAN-OR-EQUAL-TO-50 YEARS) AND WOMEN (LESS-THAN-OR-EQUAL-TO-60 YEARS) WITH CORONARY-ARTERY DISEASE [J].
KWITEROVICH, PO ;
CORESH, J ;
BACHORIK, PS .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (08) :631-639